National Cancer Plan

12:42:00

With permission, I wish to make a statement on the national cancer plan. Today is World Cancer Day. Almost everyone in our country has been affected by cancer, either themselves or through a friend or relative. Having lost both my parents to cancer, I am so grateful to the Prime Minister for giving me this job. He has given me the chance of a lifetime to do my parents proud by creating the kind of compassionate and humane healthcare that all our constituents deserve. I am also pleased to be led by a survivor of kidney cancer, my right hon. Friend the Secretary of State for Health and Social Care. His experience as a patient will be invaluable to us in the months ahead. I pay tribute to the amazing cancer charities who do fantastic work to help people live with cancer, support bereaved families and drive vital research in this area—Macmillan, Cancer Research UK, Cancer52 and Marie Curie to name just a few. Lord Darzi’s investigation set out the scale of the challenges that we face in fixing the NHS, and how desperately we need to improve cancer diagnosis rates, waits and outcomes. He found that “the UK has substantially higher rates than our European neighbours, Nordic countries, and countries that predominantly speak English”. There were close to 100,000 more cases of cancer in 2019 than in 2001. While survival rates at one year, five years and 10 years have all improved, the rate of improvement slowed substantially during the 2010s. Lord Darzi also noted important inequalities in the provision of cancer care; people in the most underserved areas are more likely to present as an emergency. As Cancer Research UK pointed out in its submission to the investigation, the 62-day target for referral to treatment has not been met for almost 10 years. Last May, performance was at just under 66%, with more than 30% of patients waiting longer than 31 days to start radical radiotherapy. For all those reasons and more, we do not have a second to waste. That is why the Prime Minister kicked off this year with our elective reform plan, setting out how we will cut the longest waiting times from 18 months to 18 weeks. From March next year, around 100,000 more people every year will be told if they have cancer or not within 28 days, and around 17,000 more people will begin treatment within two months of diagnosis. That is why this year, we will spend £70 million on replacing older radiotherapy machines with newer, more efficient models. That is why in the King’s Speech we put forward an improved Tobacco and Vapes Bill, helping to reduce around 80,000 preventable deaths and putting us on track to a smoke-free UK. While around 40% of cancers are caused by avoidable factors such as smoking, the backdrop is one of an ageing society. Cancer Research UK has forecast half a million cancer cases each year by 2040. We are preparing for the future now, with our 10-year health plan for the NHS. The plan will set out the framework of reforms that we need to ensure better outcomes and to meet the growing challenges that we face in the fight against this dreadful disease. The plan will play to Britain’s strengths as a global leader in the development of advanced therapies, using our strong academic and life sciences industry. We should remember that the NHS was the first health service in Europe to commission CAR-T cellular therapy for blood cancer patients. On this World Cancer Day, I can announce that we will build on that legacy by investing in a cutting-edge, world-leading trial to transform breast cancer care through artificial intelligence. Nearly 700,000 women will take part in this trial, testing how cutting-edge AI tools can be used to catch breast cancer cases earlier. Thirty testing sites across the country will be enhanced with the latest digital AI technologies, ready to invite women already booked in for routine screenings on the NHS to take part. The technology will assist radiologists by screening patients to identify changes in breast tissue that show possible signs of cancer, with referral for further investigations if required. If the trial is successful, it has immense potential to free up hundreds of radiologists and other specialists across the country to see more patients, tackle rising cancer rates and save more lives. It is just one example of how British scientists are at the forefront of transforming cancer care, and of the promising potential of cutting-edge innovations to tackle one of the UK’s biggest killers. This Government know that unless we do things differently, our NHS will remain in the dire state in which we inherited it. That means proper reform, from doing away with burdensome process that holds back frontline staff to handing more power to local leaders so that they can deliver for the communities they know best. It also means embracing new technologies, including AI, to transform the way we deliver care and to improve patient outcomes. Today’s trial is yet more evidence of this Government taking action to bring in the reform that is desperately needed. As the Prime Minister set out last month, our plan for change will put the UK on the front foot, unleashing AI to drive up health services and shift the NHS from analogue to digital, as part of our 10-year plan. Our 10-year plan will ensure that the NHS is there for our grandchildren and future generations, but we believe that the increasing number of cancer cases and the complexity of cancer care mean that we need a specific approach to cancer. We are determined both to bring down the number of lives cut short by cancer and to ensure that many more people go on to lead a full life after their treatment. That is why I am today announcing a call for evidence for our new national cancer plan that we will publish following the 10-year plan in the second half of this year. We will look at the full range of factors and tools that will allow us to transform outcomes for cancer patients while improving their experiences of treatment and care. We will make the United Kingdom a world leader in cancer survival by fighting the disease on all fronts—through better research, diagnosis, screening, treatment and prevention. However, we cannot do this alone, and that is why we are launching this call for evidence from patients, doctors, nurses, scientists, our key partners and other members of the public on what should be included. To support that work, we will relaunch the children and young people’s cancer taskforce, co-chaired by the hon. Member for Gosport (Dame Caroline Dinenage) and Professor Darren Hargrave, with Dr Sharna Shanmugavadivel as vice-chair. I’ve put my teeth in—apologies if I pronounced that wrong. The taskforce will bring together the country’s top experts to set out plans to improve treatment, detection and research for cancer in children, which will feed into the plan. At every stage, we will ensure that patient voices are heard. I look forward to updating the House on the progress of the plan, the taskforce and the trial throughout the year. Many of us on the Government Benches remember with pride the previous Labour Government’s record in the fight against cancer. We introduced landmark legislation to ban smoking in public places, protecting a generation of children from the harms of second-hand smoke, while putting record sums into smoking cessation programmes. At the dawn of the millennium, we launched a national cancer plan, which led to faster cancer diagnosis and treatment times, increased funding for cancer services, equipped the national health service with radiotherapy machines—many of which are still there—and expanded cancer research funding, so that a new generation of scientists could answer the call. What did that plan lead to? Survival rates went up. The number of patients diagnosed and treated on time went up. The number of lives lived well after cancer went up. That was our record in government, and we will do it again. I commend this statement to the House.

I call the shadow Minister.

12:52:00

I thank the Minister for advance sight of his statement, and I thank all the NHS workers, charities, scientists and others working to help those with cancer. We can all agree that tackling cancer should be a top priority for the NHS. From diagnosing people quickly to starting treatment quickly and using the latest technology and drugs, we all want to see improvements. The recent trends in cancer survival rates are positive. The one-year survival rate for cancer increased by 5.9% between 2010 and 2020, and the five-year survival rate increased by 4.3% in the same period. Despite those improvements, we are not yet where we want to be, and we will be up front about that. In government, we took action to catch cancer sooner and boost survival rates, with initiatives such as lung cancer screening and prostate cancer trials, and we welcome that Labour is continuing with that mission. We will work constructively with the Government on that, as we all want to achieve the same positive outcomes. However, the statement as a whole is rather disappointing. The Minister has told us that this is a cancer plan, but it is not; it is a statement that there is to be one. The Government saying that they want cancer survival rates to increase and that they are going to have a plan does not make it so—we need the plan itself. The announcement of the AI trial in breast cancer is a welcome approach. Artificial intelligence has the capacity to revolutionise the way we diagnose disease, and I am delighted that the Government wish to explore those opportunities. We also very much welcome the relaunch of the children and young people’s cancer taskforce, and are pleased it will be able to continue its valuable work under the co-chairmanship of my hon. Friend the Member for Gosport (Dame Caroline Dinenage) and Professor Darren Hargrave. It is just a shame that the Labour Government wasted seven months by suspending the Conservative taskforce, only to reinstate it now. I note the Minister’s comments about waiting times to start treatment, and we agree that these must improve. I am sure it will not have escaped his notice that NHS Wales, which has been under a Labour Administration for 25 years, has a poorer performance, and I am certain he would not want party politics to affect such an issue. Can he tell the House what conversations he is having with his Welsh counterparts to improve cancer care there? I am also concerned that last month, the Government appeared to quietly abandon the target of ensuring that patients receive treatment a maximum of 62 days from an urgent referral of suspected cancer, despite the Health Secretary having said before the election that a Labour Government would meet that target within the first term. Will the Minister clarify his commitment to the 62-day target? More scanners are, of course, welcome, but what are the Government doing to ensure that there are enough trained professionals to interpret the results of the scans effectively? With charities such as Macmillan and Marie Curie being hit with devastating increases in national insurance contributions, what help will be provided so that they do not have to cut back the vital support and guidance services they provide to cancer patients? Anyone who has faced cancer will know that time is of the essence. The second half of the year—if it is not until December—could be quite a long time from now. Will the Minister therefore be more clear about when he intends to publish the plan? May I recommend using the evidence collected in our 2022 call for evidence, as well as the policies of the interim major conditions strategy, published in 2023, to speed up the plan? The quicker the Government act, the more lives they will be able to save.

I start by genuinely thanking the shadow Minister for the co-operation she has pledged as we seek to improve the outcomes for people with cancer. This is not a party political issue. We all want people to be diagnosed more quickly and to be put on the effective treatment pathways as quickly as possible, and we all want people to have better outcomes. I would just remind her, however, that while progress was made over the past decade, as I referred to in the statement, Lord Darzi clearly set out that the rate of progress was much slower than in comparator countries, and that we could and should have been on a much better trajectory. That is why we are committed to a new national cancer plan—something for which the sector has been calling for some time. We are going to consult on that plan. I hope the shadow Minister is not suggesting that we should just pull a plan out of thin air without any consultation with the sector, patients or anybody with any interest in cancer. Of course, things have changed over recent years. New technology has advanced and scientific progress is advancing, although there are still some areas where, stubbornly, there is not enough research. We need to build up the case for research and get the funding in; I think especially of brain tumours, where, quite frankly, things have not progressed at all. We need to ensure that in the 10-year cancer plan, we really drive forward in some of those areas, using the latest technology and scientific advances. The shadow Minister asked about targets. I just say to her that we have actually strengthened targets, rather than setting new ones for cancer. Currently, the NHS is on track to deliver against its cancer targets for this year. Yes, we should be ambitious where we can, and that is exactly what this Labour Government are going to do.

I am delighted to announce to the House that we will be opening a drug trial for glioblastoma brain tumours in May, in memory of my late sister, Margaret. [Hon. Members: “Hear, hear.”] But for how long will progress on this depend on people baking cakes, running marathons and organising dinners? When will the NHS and the National Institute for Health and Care Research get their act together and do something for the 3,200 people who will be diagnosed with this dreadful illness this year?

I am very grateful to my hon. Friend for her question. Those of us who knew Margaret miss her very much; she was such a towering figure in the Labour party for so many years, and we on the Labour Benches have a lot to thank her—and, indeed, my hon. Friend—for. My hon. Friend is absolutely right on research. This is one area where, quite frankly, we have not done well enough. We have not made any progress. I know she will continue to champion more research. With our new national cancer plan, I hope that she will be pushing on an open door, because this is one area we absolutely have to do much better in.

I call the Liberal Democrat spokesperson.

Nearly every family has a cancer story, whether it is a personal fight or that of a loved one. A 10-year plan from the Government is a welcome step, as the previous Government broke their promise to implement a 10-year cancer strategy that would have made a real difference to patients. We on the Liberal Democrat Benches are very proud that our cancer campaigner, my hon. Friend the Member for Wokingham (Clive Jones), secured from the Government a commitment to introduce such a plan. Testing for cancer, diagnosing and starting treatment quickly reduces stress and anxiety. Also, if the cancer is caught early, it is more likely to be treated successfully. Yet the target of 85% of people receiving their diagnosis and starting treatment within 62 days of an urgent referral has not been met since December 2015. In my constituency, one third of cases fall short of that target and 1,000 families lose a loved one every year to this cruel disease. Lord Darzi’s review laid out very clearly that the UK has appreciably higher cancer mortality rates than other countries and that more than 30% of patients are waiting longer than 31 days for radical radiotherapy. A quarter of England’s 280 radiotherapy machines are now operating beyond their recommended 10-year lifespan, and in some areas, such as West Sussex, there is no access to radiotherapy at all. That is why we welcomed the £70 million investment announced in October to start to replace the older radiotherapy machines. Will the Minister confirm whether there will be further rounds of funding to keep pace with available radiotherapy technology? Will he look to support those at the mercy of a postcode lottery by ensuring that radiotherapy is available in all areas? What is the expected timeline for reversing the damage done by the previous Government, and when can all patients expect to start their treatment within the 62-day urgent referral target?

One reason we think a national cancer plan is so important is precisely to get the investment in the areas we need so that we can tackle those health inequalities. There are very real inequalities when it comes to the diagnosis of cancer and, more importantly, the treatment and therefore the outcomes. I am really keen that we focus on that in the plan, to ensure that all parts of the country achieve the best outcomes for people who have been diagnosed with cancer. Part of the plan is the roll-out of community diagnostic centres so that we can get diagnosis much earlier. That then puts greater pressure on getting people through the front door for treatment, so that is why, as part of the recovery plan that the Prime Minister and the Health Secretary announced, we are seeking to get more people treated more quickly on those treatment pathways. Hopefully, that will get the desired outcomes we want. It is a commitment that we will seek to restore the national health service to its constitutional standards. That is a priority of this Government. On radiotherapy machines, the £70 million investment will fund about 25 or so machines. The criteria for evaluating bids are the age of the machine, the proportion of machines aged over seven years, and the performance against the 31-day standard for radiotherapy, with poorer performers prioritised. On future rounds of funding, the cancer plan will feed into spending reviews and future Budgets. It is our priority to ensure that we reach the cancer targets, so hopefully we can make the case to the Treasury for future investment in further years.

As someone who lost his wife to cancer, I know the dire circumstances that a cancer diagnosis can bring. It is right that cancer plans should focus on the best outcomes: improving the amount of time that people live for, or having a cure. I would like to raise with the Minister the specific issue of pain relief management. As part of the plan, will he ensure that there is an investigation into how pain relief management can be improved for cancer patients, and that it is given not just during the week but at weekends too?

Absolutely. My hon. Friend raises a really important point about how people receive pain relief and how that is managed. There are some really good examples out there of how it is done really well and, shockingly, there are some that are less good. We want to learn from the best. As my right hon. Friend the Secretary of State says, it is about taking the best of the NHS to the rest of the NHS. Absolutely, that should form part of the plan.

Like many people in this House, I have seen up close and personal the devastating impact that a cancer diagnosis can have on people and families. I have also seen the difference between an early diagnosis and a later diagnosis, which is why I very much welcome the use of AI in early diagnosis. One positive by-product of having a long-standing national health service is that we have in the UK a very large database of historical tissue samples. Will the Minister consider using AI to do a retrospective analysis of those historical tissue samples to try to spot patterns that could inform future speedy diagnosis across a whole range of cancers?

I thank the right hon. Gentleman for that suggestion and will ask my officials to look into it. I am very keen that we maximise the latest advances in technology, genomics, life sciences and research to ensure that we identify people who are at risk of cancer, preferably before they develop cancer, so that we can get them on appropriate treatments where necessary and they avoid the pain and misery that cancer can bring.

On this World Cancer Day, will my hon. Friend the public health Minister tell me what efforts he is making to raise awareness of the signs and symptoms of ovarian cancer, such as a bloated tummy, lack of appetite or feeling full, tummy pain or needing to pee more often, in order to increase lifesaving early diagnosis?

I am very grateful to my hon. Friend for all the work that she has done on ovarian cancer since becoming an MP. She knows—the rest of the House might not—that I lost my mum to ovarian cancer. I was 19 when my mum died and she was only 50—my age today. She had a late diagnosis. They basically opened her up to perform a hysterectomy and the cancer had spread all the way through her body. They sewed her back up and she died at the end of a hospital ward two days later in pain and agony. Having awareness of those symptoms is so important. My mum was fobbed off by her GP, because she worked in a shop and lifted boxes. She had a bad back and was bloated and so on. The GP said it was down to her work, rather than erring on the side of caution and getting her checked out. We must ensure that women today are heard by GPs and, more importantly, that we err on the side of caution and get people on to treatment.

The Minister is absolutely right to focus on this. I warmly welcome the reinstatement of the children and young people’s cancer taskforce. I take this opportunity to pay tribute to my constituent Charlotte Fairall, who was pivotal in the work to bring the taskforce together in the first place. Charlotte’s daughter Sophie died of rhabdomyosarcoma when she was just 10 years old. I know the Minister met Charlotte to discuss this issue. Unfortunately, Sophie is not alone—around 500 children and young people die of cancer every year in the UK. It is the biggest cause of death by illness of children under the age of 14. Sophie had a wish list of things that she wanted to achieve before she died, including cooking with Gordon Ramsay and wearing high-heeled shoes, but she also wanted to meaningfully change the way we detect, treat and care for children with cancer. Does the Minister agree that the taskforce is a great step in that direction?

It absolutely is, and I thank the hon. Lady for agreeing to co-chair the re-formed taskforce. I know that she cares passionately about this issue, and it was lovely to meet Charlotte some time before Christmas. Cancer is terrible, and cancer affecting children even more so. As the hon. Lady knows, we paused the taskforce because the general election got in the way. We wanted to carry out a real-time stocktake to establish whether we needed all these different taskforces, but, along with Charlotte, she convinced me, and convinced the Secretary of State, that the work of this taskforce will be crucial to informing our national cancer plan, and I wish her all the best in securing the outcomes that both she and I want to see.

Does the Minister agree that the move from analogue to digital will be key to cancer research, especially in the field of rare cancers such as the brain tumours that we have been hearing about?

I absolutely do. That shift to analogue to digital, and the use of the latest advantages in technology, science and research, will push the boundaries of what is possible when it comes to diagnosing and treating some of the rarer cancers, on which we have made virtually zero progress in recent years. I think that, with the right direction, the right commitment and the right drive, we can really start to make inroads in this area.

May I invite the Minister, and indeed everyone here, to join us in Room M after these exchanges, when Radiotherapy UK will have a drop-in session with—most important—our patron Bryan Robson, England’s Captain Fantastic? I thank him for mentioning radiotherapy in his statement, which is crucial step forward, but may I suggest that he and the Government need to show exponentially greater ambition to get this right? The UK spends 5% of its cancer budget on radiotherapy, while the OECD average is 9%, which is why the UK is at the bottom of the survival league for so many cancers. Will the Minister commit himself to putting that right?

I am not sure that I will be able to attend the hon. Gentleman’s meeting, but I will certainly be in Westminster Hall for his debate later this afternoon. I understand exactly the concerns of people who are championing the need for increased access to radiotherapy treatments. My dad benefited from radiotherapy at the Christie, which probably gave him an extra couple of years of life with his family—I will be forever grateful for that. I get it; I understand it; we need to make the case.

I thank the Minister for his welcome statement, and join him in thanking all the organisations that do the vital work of helping and supporting those with cancer and their families. He is right to talk about health inequalities, which, as he will know, continue to worsen in constituencies such as mine, where, on average, people live 10 years less than others in more affluent areas; and last year more than 13,000 were waiting for diagnostic tests. Will he join me in commending the work of Eccleshill community diagnostic centre in Bradford— essential, and the first of its kind—which is speeding up the detection of life-threatening conditions such as cancer, and will he assure me that, as part of his national action plan, more support will be given to places such as Bradford and the Eccleshill community diagnostic centre, so that no one is left behind when it comes to their treatment?

As my hon. Friend says, tackling health inequalities is a key priority for this Government, in relation to our health mission but also more generally, when it comes to some of the big conditions such as cancer. In areas such as his and mine, the prevalence of cancer is greater, because of the industrial legacy, and also because the prevalence of smoking is still much higher than the national average. I commend the work of his local diagnostics team, and we need much more of that best practice to be spread across the areas that need it the most.

I welcome the Minister's statement. He will be aware that a routine prostate cancer screening programme would save many lives. Can he give any indication of when it will be introduced?

I am grateful to the hon. Gentleman for that question, and also for the written parliamentary questions about prostate cancer that he and a number of other Members have tabled. According to the current guidance, screening for prostate cancer is not recommended in the UK because of the inaccuracy of the current best test for prostate-specific antigen. Indeed, it could actually harm men, as some might be diagnosed with a cancer that would not have caused them problems during their lives. However, I am looking at this carefully, and I know that further information has gone to the National Institute for Health and Care Research so that it can, perhaps, reach a different conclusion. Obviously, as technology and other mechanisms advance, this may well be an area where we can make inroads, but I am happy to work with the hon. Gentleman to ensure that every opportunity is met.

I welcome this plan. I note that it was a recommendation from the Health and Social Care Committee in the last Parliament, and, as a member of that Committee, I hope that it sets a precedent. Two weeks ago I lost my brother, Alex English, to high-grade acinic cell carcinoma. While I pay tribute to all those who gave him care, can the Minister confirm that we will look at rare cancers and make sure that we research some of them and find treatments?

First, may I send my condolences to my hon. Friend and his family on the loss of his brother Alex? Of course rarer cancers are important, and they are a crucial part of what will be in the national cancer plan. It is in these areas that we must focus our efforts on diagnosis, treatment and, more importantly, getting the research done, so that we can find ways of tackling some of the very rare but deadly cancers that affect many families, including my hon. Friend’s.

In 2013, the number of breast cancer cases in women under 50 topped 10,000 for the first time, but routine breast cancer screenings are given only to women aged 40 and over. Will the Department review that and ensure that, when appropriate, initial appointments can be given to younger women? While I am at it, although the Minister might not have time to attend, may I invite everyone else to swing by my drop-in event this afternoon to discuss local health inequalities in breast cancer?

I am grateful to the hon. Lady for the work that she does in this regard. The decisions on whom to screen are made by the UK national screening committee and their advice comes to Ministers, but I am aware of the case that she has made. Screening women earlier for breast cancer should perhaps be looked at, and I will ensure that my officials look into whether we can make some progress on that for her.

Order. I know that some of these contributions are quite emotional, and if people need to leave the Chamber after they have spoken, that is okay by me.

Ethan was just 15 and studying for his GCSEs when he was diagnosed with a brain tumour. Sadly, he passed away two years later. I had the privilege of meeting his mum, Nikki, this weekend at two events organised to raise money for brain tumour research. In Ethan’s memory, will the Minister commit himself to improving outcomes for people with brain tumours through the national cancer plan?

Through my hon. Friend, I would like to pass my condolences on to Nikki for the loss of Ethan. As I have said, we have not made anything like the progress we would want to make on treatment and survival rates for brain tumours. That will form an integral part of our national cancer plan, and we will utilise all the latest advances in technology and science to try to get the better outcomes that we so desperately want.

I genuinely welcome the Minister’s commitment to the upgrading of radiotherapy machines, but I share the concerns of the chairman of the all-party parliamentary group on radiotherapy, the hon. Member for Westmorland and Lonsdale (Tim Farron), about the scale of the ambition. In defeating this horrible disease, technology and innovation is our friend. What is the Minister’s ambition for minimally invasive cancer therapies in the national cancer plan? These technologies are coming along every day, but awareness of them and the ability to get them rolled out on the frontline is slapdash at best. Will he commit to looking at those emerging therapies and getting them rolled out as soon as possible?

Absolutely. Things are advancing so quickly in technology and innovation. It is quite remarkable that science fiction is becoming science fact. We are obviously interested in minimally invasive therapies, and they will form part of the plan. That is why we are consulting. That is the purpose of this exercise: so that we can look at what technologies are here today, what the emerging technologies are and how they will shift the dial on some cancers.

The House will know that my family, like many others in Newcastle-under-Lyme, has been impacted by cancer in recent times, so I thank the Minister for his statement and his personal commitment to getting this right. On World Cancer Day, I join him in paying tribute to the charities he mentioned in his statement, and particularly my constituents Mary and Colin, who raise so much money every year for Macmillan. Health inequalities in some of our poorest communities and our ethnic minority communities play a big role in cancer being diagnosed. Can the Minister tell me and my constituents in Newcastle-under-Lyme how we will tackle those health inequalities alongside this national cancer plan?

My hon. Friend makes a very good point, and it relates to not just cancer but a whole range of conditions, including cardiovascular disease, strokes and so many others—it is the same areas that have the worst outcomes, because there are endemic health inequalities that we have not shifted the dial on for decades. Life expectancy is much lower, and healthy life expectancy is much worse, than in less deprived areas. It is part of our health mission to drive forward better health outcomes for people living in the poorest areas, and our national cancer plan will be a key part of that.

In his remarks yesterday, the Minister for Data Protection and Telecoms, the hon. Member for Rhondda and Ogmore (Chris Bryant), implied that he was discussing the future with AstraZeneca, which has had some bad news this week. AstraZeneca makes immunotherapies, among other things, and therefore is very important in allowing people to live better for longer. What discussion will the Minister be having as part of his plan with the pharmaceutical sector, since plainly the national health service cannot do this alone?

The right hon. Gentleman makes a very good point. I have certainly had a number of roundtables with the pharmaceutical sector in the UK about how we can support it, how we can grow our life sciences sector and how Britain can be at the cutting edge of new treatments and clinical trials. Indeed, we had a Delegated Legislation Committee yesterday on regulations to make it easier to carry out clinical trials in this country. Some of the latest advances in pharma are quite remarkable; I think particularly of the work being done on mRNA technology to look at having specific cancer treatments pertinent to a person’s genomics—it could be a game changer.

Hyndburn is home to the incredible woman Lorraine Hargreaves. She established the charity Milly’s Smiles after her daughter Milly died of leukaemia, and each year she supports thousands of families whose children have cancer. Can the Minister reassure her that this plan will also improve outcomes for children? I know that Lorraine will welcome the announcement on the re-establishment of the taskforce, but would the Minister consider meeting her to discuss the lack of support and grief groups for families who go through the unimaginable tragedy of losing a child to cancer?

I cannot even begin to think what it would be like to lose a child full stop, but to lose them to cancer would be horrific for their parents. I pay tribute to Lorraine for all the campaigning she has done on this. I am more than happy to meet my hon. Friend and Lorraine to talk about this, but the whole reason for putting the taskforce back on an operational footing is so that we can make the changes that she and Lorraine want to see.

Members across the House will be all too familiar with constituents reaching out to let them know that safe, effective new medicines are not approved by the National Institute for Health and Care Excellence. The Minister speaks of research and the need for access. Will he commit to being a critical friend of NICE, to ensure both good value for the taxpayer and good access for patients?

The hon. Gentleman makes a good point. NICE is there for a particular reason: to ensure that the drugs being developed are available on the NHS when they meet the required threshold. Of course, we want to ensure that as new treatments become available, they are available for British patients. The work that is being done with Moderna and other pharmaceutical companies will ensure that British patients have access to some of the latest treatments as they come through the pipeline.

One of my earliest memories is being in a hospital room as my grandfather was dying of cancer. Ten days ago, I was in the same hospital as my father died with the same cancer—50 years in between, almost to the week, but no significant change in prognosis. Can the Minister assure me that what are termed the less survivable cancers, which are not necessarily rare cancers, are included as part of this work?

My heart goes out to my hon. Friend. I lost both my parents to cancer, and it does not matter when it happens in your life; it is just heartbreaking. As the children of those parents, you never get over it. Of course, we will have a concerted effort on less survivable cancers. In part, they are less survivable because the research has not been done, or not to the extent that we can develop better treatments for them. That is where we really have to shift the dial in the next decade. We have to make sure that people who have a cancer diagnosis have the best opportunities to live a long and fulfilling life after cancer.

I declare an interest, in that I have now been smoke-free for 34 days using the NHS Quit Smoking app, even though my waistline and the Government have tested my resolve in recent weeks. Eighteen months ago we lost my office manager, Susan Hall, to lymphoma. The Minister will know that parliamentary employees are not just employees; they are part of our family. Part of her treatment was community care provided by an excellent hospice in my constituency called Mountbatten hospice. This is not meant to be a political point, but what progress has been made on looking at a fairer, Government-led mechanism to fund our hospices across the United Kingdom on an even footing and with more money?

I congratulate the hon. Gentleman on being smoke-free. Hopefully, he is the first of many as we move towards a smoke-free UK by 2030. He makes a real and serious point about not just community care—one of the big shifts in the health mission is from hospital to community—but how we approach the hospice sector. Last weekend I was at my local hospice, Willow Wood in Ashton-under-Lyne, where staff made exactly the same point. That will be fed into the national cancer plan.

I thank the Minister for his statement, and particularly for his deep understanding of women’s health issues and the difficulty that many women face in getting their GP to understand what they are going through. The Women and Equalities Committee has spent some time looking at that this year. The George Eliot hospital in my constituency serves many of my constituents, who often complain about the length of time it takes to get scan results. Between June 2023 and 2024, almost 12% of people waited more than 28 days to receive MRI results, compared with 6.5% nationally. I know that the team there are working very hard to bring the time down, but can the Minister reassure my constituents that the use of AI will speed up the time it takes for them to get their scan results and the treatment they need?

My hon. Friend makes some really important points. The need to get people scanned more quickly, and to get results to consultants, is in part why we now have extra capacity through community diagnostic centres, where there are extra facilities for scans. She is absolutely right to raise the issue of where AI and emerging technologies may take us, which will almost certainly lead to faster identification of cancers.

I thank the Minister for making his statement on World Cancer Day, and I do not doubt his sincerity on this issue. On 22 March 2022, the then Northern Ireland Health Minister launched a 10-year cancer strategy and funding plan. It was co-designed, co-produced and co-chaired by Professor Charlotte McArdle, the then chief nursing officer, and Ivan McMinn, the then chair of Cancer Focus NI. The strategy looked to adopt a regional approach, to create smoother pathways and to adopt successful innovations. It had 58 action points and was costed at £145 million per year for 10 years, but it has not really made any progress since the fall of the Northern Ireland Executive. The Minister has said that he is developing a national cancer plan. Will he meet me and the current Northern Ireland Health Minister to ensure that the work that was developed is not lost but is built into what can be a truly successful national cancer plan if we do it right?

I thank the hon. Gentleman for the work that he did in this area in a previous guise. I am more than happy to meet him and Mike Nesbitt, with whom I had a meeting on drug strategy and drugs as a public health issue before this statement, to drive forward how we can improve outcomes in Northern Ireland and get that plan working again, as it should never have stalled.

People talk about the politics of hope and, goodness me, this statement can give the country some hope that cancer survival rates will be driven up. However, the Shrewsbury and Telford hospital NHS trust has remained challenged over the last 14 years. Will my hon. Friend the Minister confirm that the areas that are most challenged will be given support to catch up and push on?

My hon. Friend makes a really important point, which is not lost on those of us on the Government Front Bench. There are real challenges across the healthcare system, and some of the areas with some of the worst outcomes also happen to have some of the worst health inequalities. Those issues are exacerbated by the pressure on the healthcare system. He can have my reassurance that the Government will make it a priority to drive down health inequalities and ensure that healthcare systems get the support they need.

I hope the Minister will join me in thanking the team at Dorset cancer centre in Poole, who enabled my step-mum, Sally Walls, to ring the bell this morning following the end of her radiotherapy treatment. Her treatment has been exceptional and swift, but the situation is inconsistent. Nikki from Horton was told that she needed a two-week appointment for gynaecological problems. When she called, she was told that it would be six weeks. She could not bear to wait, so she borrowed £650 to find out that she was all clear. Can the Minister offer reassurance that he will end the postcode lottery?

I congratulate the hon. Lady’s step-mum on ringing that bell, which is great news. The hon. Lady is absolutely right to raise the issue of inconsistency when it comes to the levels of service that different patients get. That will obviously be a major factor in the national cancer plan going forward, to ensure that all people diagnosed with cancer have the same levels of treatment and the same opportunities to survive.

I warmly welcome the Minister’s statement. He will know as well as anybody else in this Chamber that smoking causes one in four cancers in this country, and that two out of three people who smoke will die as a result. He is assiduously moving the Tobacco and Vapes Bill through Parliament. Can he set out the likely effect that the Bill will have on those shocking statistics?

I am grateful to my hon. Friend for being a member of the Committee for that Bill, which ended its business last Thursday. The hon. Members for Sleaford and North Hykeham (Dr Johnson), and for Farnham and Bordon (Gregory Stafford), who are sitting on the Opposition Front Bench, were also members of that Committee. My hon. Friend is absolutely right, because the Bill will stop the conveyor belt that the tobacco industry has used to its advantage for decades. We are saying that we will not allow any more children and young people to become addicted to nicotine and tobacco, which, as he says, kills two out of every three users. It is uniquely the most harmful product, and we are making the next generation smoke-free for a reason.

One of my constituents waited two years from the onset of severe symptoms to receive a cancer diagnosis, and another 10 weeks to have the type of cancer identified, at which point it was incurable. One of the key failings in this case seems to be the disconnect between her reporting the symptoms to her GP and getting the right referral to the hospital, despite her having a previous history of breast cancer. What promises can the Minister make on improving the co-ordination between different parts of the NHS to make sure that people like my constituent do not fall through the cracks in the future?

That kind of experience is unacceptable, and the purpose of our plan is to demand better of the NHS and the system more widely when it comes to cancer outcomes. Nobody should have the kind of experience that the hon. Lady’s constituent had, which is why we will drive better outcomes through better treatment and earlier diagnosis, and make sure that the whole NHS is joined up in the process—a key part of the national cancer plan.

Given that today is World Cancer Day, this statement is extremely welcome. Half of all leukaemia patients will not survive beyond five years, and the outlook is even bleaker for those diagnosed with acute myeloid leukaemia. If no action is taken, 80% of those diagnosed with AML today will not survive this Parliament. Early diagnosis and greater research are key to improving people’s chances. Will the Minister consider introducing measures to ensure that they are included in the national cancer plan?

My hon. Friend has my assurance on all fronts there. Early diagnosis, more and better research, and identifying how we improve outcomes for people with a variety of cancers are all crucial. His points about leukaemia are well rehearsed in the Department and will be a key part of the national cancer plan.

Some 3.4 million people in England live further than 45 minutes away from a radiotherapy centre. We all want to see that changed, but one of the challenges will be the fact that eight out of 10 radiotherapists have considered leaving the profession. Could the Minister outline what work the Government are doing to retain and recruit the radiotherapists that we need?

The hon. Member makes a reasonable point, and part of the reason that we are having a refreshed workforce plan alongside the 10-year NHS plan is precisely to address some of the concerns that he has raised. We need to make sure that we have the right workforce in the right place, and to future-proof it for the kinds of treatments that will come on stream in the coming decade.

I thank the Minister for his statement and also for the time he has spent with me discussing my private Member’s Bill, the Rare Cancers Bill. Yesterday, I met representatives of the Brain Tumour Charity, Brain Tumour Research and Pancreatic Cancer UK, and we did in part discuss the national cancer plan. I do not speak on those charities’ behalf, but one of the conclusions I drew from the discussion was that there is a real need to have the voices of rare cancer patients and survivors at the heart of this consultation. Does the Minister agree with that point? Secondly, on World Cancer Day, will he join me in wishing my daughter Ruth good luck as she trains to run a marathon in aid of the Brain Tumour Charity?

Good luck, Ruth! I hope she succeeds and raises lots of money for such a good cause. I want to thank my hon. Friend as well for his crucial work in this area. He has my assurances that at the heart of the first step, which is the call for evidence I have announced today, and of the development of the national cancer plan, those with lived experience—patients or loved ones of people who have had cancer and those who have either survived or are now bereaved—absolutely have to be at the heart of what we are doing. We will take their views, their opinions and their thoughts fully on board as we develop this plan.

I lost my father to lymphoma and my wife is an ovarian cancer survivor, so I warmly welcome this statement. In Gloucestershire, we are a designated regional cancer centre, but unfortunately the buildings at Cheltenham general are just not up to scratch any more. Fundraising was mentioned earlier by the hon. Member for Mitcham and Morden (Dame Siobhain McDonagh), and we are in that situation. We need £17.5 million and we have £9 million to go. Will the Minister warmly congratulate the Big Space Cancer Appeal fundraisers, particularly Dr Charles Candish and Dr Sam Guglani, who are leading the charge on that? Would he like to meet those consultants to discuss how we might move this fundraising effort along so that the whole project does not rest on the back of charity?

I am more than happy to meet the hon. Member and the team to look at precisely those points and I wish them all the very best in their fundraising efforts, but look, as a country we are better than this. I want to see the national cancer plan really start to address how we can get that research, that treatment, those diagnoses and those better outcomes for people with the NHS at the heart of it, doing what the NHS does best and ensuring that we get those outcomes from publicly funded improvements.

I welcome all the efforts this Government are making to improve cancer services. Early diagnosis is just as important as prevention, but we all know that patients are currently waiting several months for scan procedures. A recent visit to the GP surgeries in my constituency showed that they have spare capacity for scanning, but it is not actively offered to patients at the moment. This is due to a lack of collaborative working and communication in the health system, so will the Minister tell the House how we can improve the existing systems so that they work effectively and people can get timely procedures?

Part of our recovery plan is to ensure that we return the national health service to constitutional standards, not just in respect of cancer but across the board. We inherited a broken national health service and it is incumbent on this Government to fix it and make it fit for the future. Clearly, in areas such as my hon. Friend’s, the NHS needs to be doing much better when it comes to cancer outcomes and cancer treatments, and this plan and this Government will ensure that his local system gets all the support it needs.

I declare an interest, as I have a family member who has shares in a medical company. I pay tribute to the Minister for following through with his promise for a national cancer plan. It is clearly very important to him, and it is to me as well. Shaun Walsh of Cancer Research UK first raised with me the need for a dedicated cancer plan, and it has been an important part of my work in Parliament since then. Will the Minister meet me and Shaun to discuss the next steps for the national cancer plan?

I am more than happy to do so. My diary secretary, who will be watching this from the Department of Health, is probably having kittens at the amount of meetings. I meet Shaun and the cancer charities frequently anyway, and as I said at the start of the statement, I commend the work that they do in this area. This national cancer plan is important to me, to the Secretary of State, to the Prime Minister and to the sector, and that is why we are doing the right thing and having a plan.

I welcome today’s statement and I know that my wife, Julia, who is a consultant radiographer in mammography at King’s Mill hospital, will also welcome it. One of my earliest childhood memories is of watching my grandfather, William Yemm, die of lung cancer. William was a lifelong coalminer at Blidworth colliery. I think he drank and smoked rather more than was good for him throughout his life, so does the Minister agree that prevention is every bit as important as diagnosis, treatment and research in the fight against cancer? Can he reassure me that this welcome national cancer plan will consider what action we can take to prevent people from developing cancer?

My hon. Friend raises such an important point. This Government have three shifts and I have mentioned two of them already: the shifts from hospital to community and from analogue to digital. The third shift is from sickness to prevention. We absolutely have to shift the dial, whether it is on alcohol harms, smoking, obesity, inactivity or the air we breathe. These are the five-point plan priorities when it comes to prevention. My hon. Friend is so right to focus on this, and we hope to cut the instances of a whole range of preventable illnesses, including cancer.

Many of my constituents have to travel to England to access cancer treatment. This presents many problems, one of which is a lack of data sharing between NHS England and NHS Wales. Will the Minister assure Welsh patients that if they are treated in an English hospital, their data will follow them home and that it will be accessible to NHS Wales?

The hon. Gentleman raises an important point. I also have regular meetings with ministerial colleagues in the Welsh Government, and this is an area of interest to both Governments. We need to make sure there is better sharing of data and information for patients from Wales, Scotland and Northern Ireland when accessing NHS services in England, so that there is joined-up, smarter use of the data held on patients by our respective NHS systems in order to get better outcomes. I assure the hon. Gentleman that I am already taking this up with ministerial colleagues across the devolved Administrations.

I thank the Minister for his statement. Since my election, I have met a wide range of cancer charities, especially those representing rare and less common cancers. As the Minister knows, 55% of UK cancer deaths are a result of those types of cancers, such as blood, ovarian and kidney cancers. Will he ensure that rare and less common cancers are not forgotten in the national cancer plan?

My hon. Friend has my full assurance that all cancers—all tumour types—will be an integral part of the national cancer plan. On rarer cancers, it is important that we use the call for evidence and the discussions we will have in the coming weeks and months to ensure that those voices are heard as we drive forward our plan.

I thank the Minister for his statement. His words always display the compassion and comfort that these types of statements should convey. Does the Minister agree that it is time for the Government to do more to fund cancer research, rather than leaving charities to bear the burden? Cancer Research UK alone has invested more than £4 billion in research over the last 10 years. Will this plan ensure that groundbreaking research, such as that carried out at Queen’s University Belfast, will have enhanced funding for a world-class breakthrough in finding a cure for cancer? Will Northern Ireland be one of the UK’s 30 testing sites for women?

I thank my hon. Friend. I always call him my hon. Friend because I see more of him than I see of my wife. [Laughter.] Usually because we are in the same debates. The hon. Member makes an important point about research, which will be a crucial aspect of the national cancer plan. Advances in technology, science and pharmaceuticals do not happen by accident; they happen because we fund the research to get to that point. We need to do much better in researching some of the rarer and less survivable cancers. Those scientists and charities must have access to the funds that are available so they can carry out the research we need. As for where the 30 sites will be, that is above my pay grade. There are criteria, but I will take it back to my officials and see what we can do.

I thank the Minister for his statement, and I thank every Member on both sides of the Chamber who has shared their personal stories. I was nine years old when I lost my grandmother, Grace, to cancer. That was a long time ago, but it still has a profound effect on me. Does the Minister agree that early detection is vital for survival rates? In particular, I emphasise the point about the importance of ensuring that women are taken seriously when they visit their GP. I thank my constituent Sir Rod Stewart for the support he gave to the radiography department at Princess Alexandra hospital. Does the Minister agree that this national cancer plan will mean that we do not have to rely on the good will of rock legends such as Rod Stewart to support everyone in our society?

Talk about name-dropping; if only I had such famous constituents. Burnage was once home to the Gallagher brothers, and Denton was home to Mick Hucknall—I do not think any of them live there any more. My hon. Friend makes an important point that women, in particular, have to be taken seriously by their GPs. The symptoms of some of these cancers could indicate a multitude of different things but, knowing from my mum’s bitter experience, I would sooner that GPs erred on the side of caution and got people diagnosed. If the diagnosis turns out not to be cancer, what a wonderful result that is. If it is cancer, we can get them on the treatment pathway sooner rather than later.

I also commend the Minister for his great announcement, which is welcome and needed. The Minister has often spoken about the importance of shifting from sickness to prevention, from hospital to community, and from analogue to digital. Residents of Southend East and Rochford deserve an NHS that is there when they need it. What impact does he think the plan will have on the issues he has outlined today?

My hon. Friend raises an important point, and it is a good one on which to end. Each of those three shifts—from hospital to community, from analogue to digital, and from sickness to prevention—could be taken in isolation. However, by putting them together, we can shift how we deliver health and care in this country. We will make it fit for purpose, we will drive up standards across the system, we will get the NHS back to constitutional standards—which means lower waiting times, shorter waiting lists and better outcomes—and, when it comes to cancer, we will save lives. It is as simple as that. Bill Presented Statutory Adoption Pay (Report on Extension to the Self-Employed) Bill Presentation and First Reading (Standing Order No. 57) Lisa Smart presented a Bill to require the Secretary of State to report to Parliament on the merits of extending eligibility for statutory adoption pay to persons who are self-employed or contractors; and for connected purposes. Bill read the First time; to be read a Second time on Friday 7 March, and to be printed (Bill 175).